Patents by Inventor Joseph Moreau

Joseph Moreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10410305
    Abstract: An exception-based integrated patient access workflow via a single user interface is provided. When patient data associated with a healthcare encounter is received, various rules may be applied to cross-check the received data with other stored and received data to ensure correct patient data and to ensure accurate information for downstream patient access workflow processes. An indication of discrepant data, missing data, or input/user-interaction that may be needed for performance of a patient access workflow process may be provided. The indication may be provided via alerts displayed in an integrated user interface. Accordingly, a user may be able to address and resolve alerts to ensure patient access workflow processes are performed prior to a healthcare encounter.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: September 10, 2019
    Assignee: EXPERIAN HEALTH, INC.
    Inventors: Edmond Chase Pilkington, Joseph M. Magee, III, Howard Bright, Michael Moreau, Lance Mansfield, Marcus Padgett
  • Publication number: 20180230145
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Application
    Filed: February 6, 2018
    Publication date: August 16, 2018
    Inventors: Arnab Kumar CHATTERJEE, Advait Suresh NAGLE, Prasuna PARASELLI, Ravinder Reddy KONDREDDI, Seh Yong LEONG, Pranab Kumar MISHRA, Robert Joseph MOREAU, Jason Thomas ROLAND, Wei Lin Sandra SIM, Oliver SIMON, Liying Jocelyn TAN, Bryan KS YEUNG, Bin ZOU, Venkatataiah BOLLU
  • Patent number: 9926314
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Grant
    Filed: July 26, 2016
    Date of Patent: March 27, 2018
    Assignee: Novartis AG
    Inventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan K S Yeung, Bin Zou, Venkatataiah Bollu
  • Patent number: 9556169
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: January 31, 2017
    Assignee: Novartis AG
    Inventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Jocelyn Liying Tan, Bryan K S Yeung, Bin Zou, Venkatataiah Bollu
  • Publication number: 20160333012
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Application
    Filed: July 26, 2016
    Publication date: November 17, 2016
    Applicant: NOVARTIS AG
    Inventors: Arnab Kumar CHATTERJEE, Advait Suresh NAGLE, Prasuna Paraselli, Ravinder Reddy KONDREDDI, Seh Yong LEONG, Pranab Kumar MISHRA, Robert Joseph MOREAU, Jason Thomas ROLAND, Wei Lin Sandra SIM, Oliver SIMON, Jocelyn Liying TAN, Bryan KS YEUNG, Bin ZOU, Venkatataiah BOLLU
  • Publication number: 20150344471
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Application
    Filed: November 18, 2013
    Publication date: December 3, 2015
    Applicant: NOVARTIS AG
    Inventors: Arnab Kumar CHATTERJEE, Advait Suresh NAGLE, Prasuna PARASELLI, Ravinder Reddy KONDREDDI, Seh Yong LEONG, Pranab Kumar MISHRA, Robert Joseph MOREAU, Jason Thomas ROLAND, Wei Lin Sandra SIM, Olive SIMON, Liying Jocelyn TAN, Bryan KS YEUNG, Bin ZOU, Venkatataiah BOLLU
  • Publication number: 20150011522
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Application
    Filed: September 22, 2014
    Publication date: January 8, 2015
    Applicants: IRM LLC, Novartis AG
    Inventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan KS Yeung, Bin Zou, Venkatataiah Bollu
  • Patent number: 8871754
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Grant
    Filed: November 18, 2013
    Date of Patent: October 28, 2014
    Assignees: IRM LLC, Novartis AG
    Inventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan K S Yeung, Bin Zou, Venkatataiah Bollu
  • Publication number: 20140155367
    Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.
    Type: Application
    Filed: November 18, 2013
    Publication date: June 5, 2014
    Applicants: Novartis AG, IRM LLC
    Inventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan KS Yeung, Bin Zou, Venkatataiah Bollu
  • Publication number: 20050263092
    Abstract: An elevated-beam cow stall assembly has a plurality of tubular cow stall dividers supported on a single horizontal beam. This provides room for the cow to lunge slightly to assist her in lying down or getting up. In an embodiment, stanchions or brackets are formed of vertical channel members affixed onto the beam. The tubular stall dividers each have an upper and a lower horizontal rail, the ends of which are mounted into the upper and lower ends of the channel member. Short upper and lower channel portions are fastened to the main vertical channel members, web-to-web, and the tubular stall dividers from a facing row of stalls are mounted on these. The brackets or stanchions may be mounted to the beam using square U-bolts, or by other techniques such as welding.
    Type: Application
    Filed: July 19, 2005
    Publication date: December 1, 2005
    Inventor: Joseph Moreau
  • Publication number: 20050148745
    Abstract: Process for the preparation of a copolymer of maleic anhydride and an alkyl vinyl ether, comprising the steps of supplying maleic anhydride and the alkyl vinyl ether and an initiator, together forming a feed flow, through an inlet to a reactor wherein maleic anhydride and the alkyl vinyl ether react to a copolymer of maleic anhydride an alkyl vinyl ether thereby forming a reaction mixture with the maleic anhydride, the alkyl vinyl ether and the initiator characterized in that the process is a continuous process and the reactor is a loop reactor wherein the reaction mixture is internally circulated, whereby this reaction mixture arrives at the inlet before the maleic anhydride and alkyl vinyl ether have completely reacted while a remainder of initiator is still present. The invention further relates to copolymer of maleic anhydride and alkyl vinyl ether, including hydrolyzed or alcoholized copolymers, characterized in that a molecular weight distribution, expressed as Mw/Mn, is less than 2.
    Type: Application
    Filed: January 22, 2003
    Publication date: July 7, 2005
    Inventors: Rudolfus Antonius Theodorus Benthem Van, Joseph Friederichs, Dominique Jean Joseph Moreau
  • Publication number: 20050072371
    Abstract: An elevated-beam cow stall assembly employs angle brackets each installed on a respective vertical post. Support stanchions formed of a vertical rail, with upper and receiver members affixed at upper and lower ends of the rail, are attached to the back plates of the angle brackets, and the back plates also support the horizontal support beam. Tubular stall dividers each have an upper and a lower horizontal rail, the ends of which are mounted into the receivers of the stanchions. Additional stanchions may be affixed, i.e., with U-bolts, at intermediate locations along the horizontal beam, and these stanchions also support associated stall dividers. Neck rails may be attached to the upper rails of the dividers, and brisket rails or brisket pipes may be supported on the lower rails of the dividers. This construction permits an unobstructed space below the horizontal beam to give the cow some freedom of movement for lying down and rising.
    Type: Application
    Filed: September 19, 2003
    Publication date: April 7, 2005
    Inventor: Joseph Moreau